Distribution date: 28 November 2006 | Final date for Comment: 05 May 2025

Products Covered: Paints and varnishes (HS:  320910; ICS:  87.040)

Regulation Type: Regular notification

Distribution date: 08 December 2006 | Final date for Comment: 05 May 2025

MRLs for the veterinary drug Nitrofurazone are proposed to be revoked since the use of this drug has been banned.

Products Covered: Cattle, pigs, sheep, goats and poultry.

Regulation Type: Regular notification

Distribution date: 08 December 2006 | Final date for Comment: 05 May 2025

MRLs for the veterinary drug Nitrofurazone are proposed to be revoked since the use of this drug has been banned.

Products Covered: Cattle, pigs, sheep, goats and poultry.

Regulation Type: Regular notification

Distribution date: 18 December 2006 | Final date for Comment: 05 May 2025

This Application seeks to amend the Australia New Zealand Food Standards Code (the Code) to align the maximum residue limit (MRL) for the antibiotic oxytetracycline in honey with other national regulations relating to the safe and effective use of agricultural and veterinary chemicals.

Products Covered: Foods in general

Regulation Type: Regular notification

Distribution date: 18 December 2006 | Final date for Comment: 05 May 2025

This Application seeks to amend the Australia New Zealand Food Standards Code (the Code) to align the maximum residue limit (MRL) for the antibiotic oxytetracycline in honey with other national regulations relating to the safe and effective use of agricultural and veterinary chemicals.

Products Covered: Foods in general

Regulation Type: Regular notification

Distribution date: 18 December 2006 | Final date for Comment: 05 May 2025

The Food and Drug Administration (FDA) is proposing to amend its final rule that established standardized format and content requirements for the labelling of over-the-counter (OTC) drug products (Drug Facts Rule, codified at 21 CFR 201.66). This amendment proposes a definition and the option of alternative labeling requirements for "convenience-size" OTC drug packages.

Products Covered: Over-the-counter human drugs (HS:  Chapter 3004) (ICS:  11)

Regulation Type: Regular notification

Distribution date: 18 December 2006 | Final date for Comment: 05 May 2025

The Food and Drug Administration (FDA) is proposing to amend its final rule that established standardized format and content requirements for the labelling of over-the-counter (OTC) drug products (Drug Facts Rule, codified at 21 CFR 201.66). This amendment proposes a definition and the option of alternative labeling requirements for "convenience-size" OTC drug packages.

Products Covered: Over-the-counter human drugs (HS:  Chapter 3004) (ICS:  11)

Regulation Type: Regular notification

Distribution date: 22 December 2006 | Final date for Comment: 05 May 2025

The EPA is reopening the public comment period for a proposed significant new use rule (SNUR) published in the Federal Register of 12 May 1993 (58 FR 27980) for the chemical chloranil (2,3,5,6-tetrachloro-2,5-cyclohexadiene-1,4-dione). EPA is planning to complete this rulemaking by issuing a final rule. Given the long period of time which has passed since EPA issued the proposed rule, EPA is reopening the comment period. This will provide an opportunity for commenters to update their comments and for additional commenters to contribute to the docket before EPA develops a final rule.

Products Covered: (HS:  Chapter 3808; ICS:  71)

Regulation Type: Regular notification

Distribution date: 22 December 2006 | Final date for Comment: 05 May 2025

The EPA is reopening the public comment period for a proposed significant new use rule (SNUR) published in the Federal Register of 12 May 1993 (58 FR 27980) for the chemical chloranil (2,3,5,6-tetrachloro-2,5-cyclohexadiene-1,4-dione). EPA is planning to complete this rulemaking by issuing a final rule. Given the long period of time which has passed since EPA issued the proposed rule, EPA is reopening the comment period. This will provide an opportunity for commenters to update their comments and for additional commenters to contribute to the docket before EPA develops a final rule.

Products Covered: (HS:  Chapter 3808; ICS:  71)

Regulation Type: Regular notification

Distribution date: 22 December 2006 | Final date for Comment: 05 May 2025

Final Rule: The Food and Drug Administration (FDA) has amended the nutrition labeling regulations for dietary supplements to provide that the quantitative amount and the percent of Daily Value of a dietary ingredient may be voluntarily presented on a "per day" basis in addition to the required "per serving" basis when a recommendation is made on the label that the dietary supplement be consumed more than once per day. This final rule responds to a citizen petition requesting that FDA amend our dietary supplement nutrition labeling regulations to include this provision. FDA is taking this action to give manufacturers of dietary supplements the option to present nutrition information on a "per day" basis to consumers.

Products Covered: Dietary supplements  (HS:  Chapter 3004) (ICS 11, 67, 71)

Regulation Type: Regular notification